Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease.
Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease.
复制标题
人参中的人参皂苷:有望治疗炎症性肠病
DOI:
10.1007/s43440-020-00213-z
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Liu D
中科院分区:
文献类型:
--
作者:
Kang Z;Zhonga Y;Wu T;Huang J;Zhao H;Liu D
Inflammatory bowel disease (IBD) is an autoimmune disease mediated by immune disorder and termed as one of the most refractory diseases by the Word Health Organization. Its morbidity has increased steadily over the past half century worldwide. Environmental, genetic, infectious, and immune factors are integral to the pathogenesis of IBD. Commonly known as the king of herbs, ginseng has been consumed in many countries for the past 2000 years. Its active ingredient ginsenosides, as the most prominent saponins of ginseng, have a wide range of pharmacological effects. Recent studies have confirmed that the active components of Panax ginseng have anti-inflammatory and immunomodulatory effects on IBD, including regulating the balance of immune cells, inhibiting the expression of cytokines, as well as activating Toll-like receptor 4, Nuclear factor-kappa B (NF-κB), nucleotide-binding oligomerization domain-like receptor (NLRP), mitogen-activated protein kinase signaling, and so on. Accumulated evidence indicates that ginsenosides may serve as a potential novel therapeutic drug or health product additive in IBD prevention and treatment in the future.
登录
查看更多内容
影响因子:
2.4
作者:
Bischoff SC;Barbara G;Buurman W;Ockhuizen T;Schulzke JD;Serino M;Tilg H;Watson A;Wells JM
通讯作者:
Wells JM
影响因子:
32.4
作者:
Huber S;Gagliani N;Esplugues E;O'Connor W Jr;Huber FJ;Chaudhry A;Kamanaka M;Kobayashi Y;Booth CJ;Rudensky AY;Roncarolo MG;Battaglia M;Flavell RA
通讯作者:
Flavell RA
影响因子:
7.5
作者:
Dai, Shanshan;Hong, Yilian;Gu, Xuejiang
通讯作者:
Gu, Xuejiang
影响因子:
5.2
作者:
Hong, Yilian;Lin, Yi;Gu, Xuejiang
通讯作者:
Gu, Xuejiang
影响因子:
7.5
作者:
Chen, Xu;Wang, Qiyan;Wang, Yong
通讯作者:
Wang, Yong